← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE
NDA · New Drug Application · Sponsor: MICRO LABS · Approved 2018-08-13
Drug application
- FDA Application #
NDA205626- Application type
- New Drug Application
- Brand name
- LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- MICRO LABS
- First approval
- 2018-08-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown